Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 10 , Pages 808-816 , October 2011

Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: Role of NO and prostanoids

  • N.S. Lobato

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • F.P. Filgueira

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • E.H. Akamine

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • A.P.C. Davel

      Affiliations

    • Department of Physiology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil
    • ,
  • L.V. Rossoni

      Affiliations

    • Department of Physiology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil
    • ,
  • R.C. Tostes

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • M.H.C. Carvalho

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • Z.B. Fortes

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil
    • Corresponding Author InformationCorresponding author. Tel./fax: +55 11 3091 7317.

Received 3 August 2009 ,Revised 5 February 2010 ,Accepted 8 February 2010.

References 

  1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727
  2. Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006;27:750–761
  3. Echahidi N, Mohty D, Pibarot P, Després JP, O'hara G, Champagne J, et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation. 2007;116(11):I213–I219
  4. Stapleton PA, James ME, Goodwill AG, Frisbee JC. Obesity and vascular dysfunction. Pathophysiology. 2008;15(2):79–89
  5. Barton M, Furrer J. Cardiovascular consequences of the obesity pandemic: need for action. Expert Opin Investig Drugs. 2003;12:1757–1759
  6. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164:719–721
  7. Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res. 1997;30:671–674
  8. Tokarev D, Kristová V, Kriska M, Jezová D. Treatment of neonatal rats with monosodium glutamate attenuates the cardiovascular reactivity to phenylephrine and angiotensin II. Physiol Res. 1997;46(3):165–171
  9. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol. 1997;273:E202–E206
  10. Macho L, Fickova M, Jezova , Zorad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res. 2000;49:S79–S85
  11. Messina MM, Evans AS, Swoap SJ, Overton JM. Perinatal MSG treatment attenuates fasting-induced bradycardia and metabolic suppression. Physiol Behav. 2005;86:324–330
  12. Tokuyama K, himms-hagen J. Adrenalectomy prevents obesity in glutamate-treated mice. Am J Physiol. 1989;237:E139–E144
  13. Dolnikoff M, Martín-Hidalgo A, Machado UF, Lima FB, Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord. 2001;25(3):426–433
  14. Könner AC, Klöckener T, Brüning JC. Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond. Physiol Behav. 2009;97(5):632–638
  15. Akamine EH, Kawamoto EM, Scavone C, Nigro D, Carvalho MH, Tostes RC, et al. Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J Vasc Res. 2006;43(4):309–320
  16. Matthew DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function form fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  17. Mc Gregor DD. The effect of sympathetic nerve stimulation of vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol. 1965;177:21–30
  18. Xavier FE, Rossoni LV, Alonso MJ, Balfagón G, Vassallo DV, Salaices M. Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries. Br J Pharmacol. 2004;143:215–225
  19. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998;70:2446–2453
  20. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in Spontaneously Hypertensive Rats. Hypertension. 1995;25:1083–1089
  21. Davel AP, Fukuda LE, De Sá LL, Munhoz CD, Scavone C, Sanz-Rosa D, et al. Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. Am J Physiol Heart Circ Physiol. 2008;295(1):H211–H219
  22. De Vriese AS, Verbeuren TJ, Voorde JV, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963–974
  23. Carvalho MH, Scivoletto R, Fortes ZB, Nigro D, Cordellini S. Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium. J Hypertens. 1987;5(3):377–382
  24. Moreno G, Perello M, Camihort G, Luna G, Console G, Gaillard RC, et al. Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rat. Int J Obes. 2006;30:73–82
  25. de Carvalho Papa P, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci. 2002;71(16):1917–1928
  26. Morris MJ, Tortelli CF, Filippis A, Proietto J. Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. Regul Pept. 1998;75:441–447
  27. Ritchie SA, Ewart MA, Perry CG, Connell JM, Salt IP. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci. 2004;107(6):519–532
  28. Perelló M, Gaillard RC, Chisari A, Spinedi E. Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology. 2003;78(3):176–184
  29. Perelló M, Moreno G, Gaillard RC, Spinedi E. Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity. Neuro Endocrinol Lett. 2004;25(1–2):119–126
  30. Lijnen HR. Angiogenesis and obesity. Cardiovasc Res. 2008;78(2):286–293
  31. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology. 2005;146(10):4545–4554
  32. Martins AC, Souza KL, Shio MT, Mathias PC, Lelkes PI, Garcia RM. Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity. Life Sci. 2004;74(26):3211–3222
  33. Lucinei Balbo S, Gravena C, Bonfleur ML, de Freitas Mathias PC. Insulin secretion and acetylcholinesterase activity in monosodium l-glutamate-induced obese mice. Horm Res. 2000;54(4):186–191
  34. Stepp DW, Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol. 2002;282:H816–H820
  35. Ghatta S, Ramarao P. Increased contractile responses to 5-hydroxytryptamine and Angiotensin II in high fat diet fed rat thoracic aorta. Lipids Health Dis. 2004;3:19
  36. Villar IC, Francis S, Webb A, Hobbs AJ, Ahluwalia A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int. 2006;70:840–853
  37. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease. Circulation. 2006;113:1708–1714
  38. Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, et al. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis. 2008;198(1):65–76
  39. Szerafin T, Erdei N, Fulop T, Pasztor ET, Edes I, Koller A, et al. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res. 2006;99:e12–e17
  40. Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, Vetter W, et al. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens. 2002;20:2239–2245
  41. Stepp DW, Boesen EI, Sullivan JC, Mintz JD, Hair CD, Pollock DM. Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am J Physiol Heart Circ Physiol. 2007;293(4):H2537–H2542
  42. Frisbee JC. Impaired dilation of skeletal muscle microvessels to reduced oxygen tension in diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol. 2001;281:H1568–H1574
  43. Moncada S, Rees DD, Schulz R, Palmer RM. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA. 1991;88:2166–2170

PII: S0939-4753(10)00041-4

doi: 10.1016/j.numecd.2010.02.006

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 10 , Pages 808-816 , October 2011

Article Tools

* Image Usage & Resolution